Simple breathing tool may boost recovery after liver transplant
NCT ID NCT07318766
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether using an incentive spirometer—a device that encourages slow, deep breathing—can improve blood oxygen levels and recovery in people who just had a liver transplant. Forty adults between 18 and 65 years old took part. The goal was to see if this simple breathing exercise could help them get out of the hospital sooner.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Incentive spirometer (a device that encourages slow, deep breathing)
- What this could lead to
- If it works, this could point toward a simple, low-cost way to help liver transplant patients breathe better and recover faster after surgery.
- What could go wrong
- This is a small, completed trial with only 40 participants, so results may not apply to everyone. The device is used alongside standard care, so any benefit may be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
40 people
The number who actually took part.
- Started
-
Nov 2024
- Finished
-
Nov 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. age between 18 and 65 years, 2. scheduled to undergo Living Donor Liver Transplant (LDLT) as recipients 3. able to understand and follow instructions for incentive spirometry use Exclusion Criteria: 1. multiorgan transplantation 2. moderate-to-severe pleural effusion at baseline 3. persistent elevation in renal function tests 4. history of bleeding esophageal varices within the preceding month 5. multicentric hepatocellular carcinoma (HCC) 6. active smoking 7. decompensated cardiac disease 8. alcoholic hepatitis as the primary etiology 9. cognitive impairment or blindness precluding participation in the rehabilitation protocol.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Liver transplant disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
El Sahel Teaching hospital
Cairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Device aims to keep donor livers healthier for transplant
- Teleyoga tested for liver transplant recovery
- AI coach for transplant patients: will it cut hospital stays?
- Carotid ultrasound may help guide fluid management in liver transplants
- New registry tracks best way to fix bile duct blockages in liver transplant patients
- New test may help doctors pick better livers for transplant